A clinical collaboration exploring how NaoTrac can support careful, target-based delivery in brain care.
For patients living with a difficult neurological condition, hope often begins with a question: is there another option worth exploring?
But in brain care, a possible treatment idea is only part of the journey. The next question is just as important: can it be delivered to the right place with precision, stability, and care?
In this case, the question was different: could navigation help deliver a patient’s own stem cells to a planned target area in a more stable and precise way?
This question became central in a clinical collaboration between Brain Navi and Hualien Tzu Chi Hospital involving a patient with spinocerebellar ataxia, or SCA. The approach involved autologous stem cells, meaning cells derived from the patient’s own body.
In this clinical exploration, one of the key challenges was not only where to deliver the cells, but how to reach the target area through a safe and practical workflow.
Traditional frame-based approaches may require frame placement and may create limitations in patient positioning, surgical access, and procedural preparation. For certain target-based procedures, these factors can add complexity for both the clinical team and the patient.
NaoTrac offers a different approach.
In this case, prone positioning was important. The patient needed to be positioned in a way that allowed the clinical team to approach the target area more directly.
NaoTrac supports this by using machine vision-based facial surface registration, allowing the team to register the patient without relying on a traditional stereotactic frame. This frame-free workflow gives the surgical team more flexibility in positioning, planning, and access.
For procedures that require careful delivery to a specific brain target, this flexibility matters. It can help the team plan a more stable path, support a more ergonomic approach for the surgeon, and create a more controlled route to the target area.
New approaches in brain health often take time. Some clinical explorations may not lead to the level of improvement originally hoped for. But they can still teach us something valuable. They can show whether a workflow is feasible, whether a pathway can be planned more clearly, and whether technology can help reduce some of the limitations that made certain procedures harder to perform in the past.
This is part of responsible innovation.
NaoTrac’s role in this SCA clinical exploration reflects a broader idea: navigation technology is not only about reaching a target. It can also help open the door to new clinical possibilities by making complex procedures more structured, practical, and repeatable.
No technology can promise recovery. And no single procedure can answer all the challenges of a progressive neurological condition.
But for patients living with SCA, and for the families who walk beside them, progress often begins with careful steps: a better workflow, a more precise path, and a treatment idea explored with more structure and care.
Protecting brain health means continuing to ask what more can be done, especially for conditions where answers are still limited.
And sometimes, the next step begins with finding a better way to reach the place where new possibilities are being explored.
This article is intended for educational and awareness purposes only. Cell-based approaches for SCA remain investigational and require appropriate clinical, ethical, and regulatory oversight.